Zacks Investment Research on MSN
BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock?
BridgeBio Pharma (BBIO) shares ended the last trading session 17.1% higher at $63.56. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback